Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioLineRx Announces Initiation of Triple Combination Arm of Pancreatic Cancer Study

americanpharmaceuticalreviewDecember 12, 2018

Tag: BioLineRx , Pancreatic cancer , PDAC , Triple Combination Arm

PharmaSources Customer Service